Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

CanaFarma Hemp Products Corp

Healthcare US CNFHF

0.0001USD
0.00(0%)

Last update at 2026-06-02T20:00:00Z

52 Week Range

0.00010.0001
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.02M
  • Volume10068
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-13.63155M
  • Revenue TTM0.77M
  • Revenue Per Share TTM0.004
  • Gross Profit TTM -4.31228M
  • Diluted EPS TTM-0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2020-06-30 2019-06-30 2018-06-30
Type yearly yearly yearly
Date 2020-06-30 2019-06-30 2018-06-30
Income before tax -18.96310M -0.02593M -0.00701M
Minority interest 1.16M -0.08768M -
Net income -17.80135M -0.02593M -0.00701M
Selling general administrative 7.14M 0.03M 0.00697M
Selling and marketing expenses - - -
Gross profit -2.32383M - -
Reconciled depreciation 0.20M - -
Ebit -10.06199M -3.74701M -
Ebitda -9.39495M -0.02586M -0.00697M
Depreciation and amortization - - -
Non operating income net other - - -
Operating income -9.59673M -0.02586M -0.00697M
Other operating expenses - - -
Interest expense 0.00000M 0.00000M 0.00000M
Tax provision 0.00003M - -
Interest income - - -
Net interest income - -0.00007M -0.00005M
Extraordinary items - - -
Non recurring - - -
Other items - - -
Income tax expense 0.00003M 0.00007M -
Total revenue 1.80M - -
Total operating expenses 11.40M 0.03M 0.00697M
Cost of revenue 4.13M - -
Total other income expense net -9.36637M - -
Discontinued operations - - -
Net income from continuing ops -18.96312M -0.02593M -0.00701M
Net income applicable to common shares -17.80135M -3.48406M -
Preferred stock and other adjustments - - -
Breakdown 2020-06-30 2019-06-30 2018-06-30
Type yearly yearly yearly
Date 2020-06-30 2019-06-30 2018-06-30
Total assets 6.76M 0.00249M 0.01M
Intangible assets 0.77M - -
Earning assets - - -
Other current assets 0.32M 1.17M -
Total liab 6.86M 0.01M 0.00282M
Total stockholder equity -0.09901M -0.00885M 0.01M
Deferred long term liab - - -
Other current liab 5.63M 0.17M -
Common stock 22.79M 5.74M -
Capital stock 22.79M 0.02M -
Retained earnings -20.21215M -1.16135M -0.00789M
Other liab - - -
Good will - - -
Other assets - - -
Cash 1.01M 0.00000M 0.01M
Cash and equivalents - - -
Total current liabilities 6.86M 0.48M 0.00282M
Current deferred revenue - - -
Net debt - 0.00379M -
Short term debt - - -
Short long term debt - 0.00379M 0.00245M
Short long term debt total - - -
Other stockholder equity -2.68163M - -
Property plant equipment 0.69M 0.15M -
Total current assets 5.30M 3.92M 0.01M
Long term investments - - -
Net tangible assets -0.87230M 3.67M -
Short term investments - - -
Net receivables 3.80M 0.05M -
Long term debt - - -
Inventory 0.10M 0.52M -
Accounts payable 1.08M 0.02M 0.00037M
Total permanent equity - - -
Noncontrolling interest in consolidated entity - - -
Temporary equity redeemable noncontrolling interests - - -
Accumulated other comprehensive income - - -
Additional paid in capital - - -
Common stock total equity - - -
Preferred stock total equity - - -
Retained earnings total equity - - -
Treasury stock - - -
Accumulated amortization - - -
Non currrent assets other - - -
Deferred long term asset charges - - -
Non current assets total 1.46M 0.00000M 0.00000M
Capital lease obligations - - -
Long term debt total - - -
Breakdown 2020-06-30 2019-06-30 2018-06-30
Type yearly yearly yearly
Date 2020-06-30 2019-06-30 2018-06-30
Investments -0.65936M 0.00000M 0.00000M
Change to liabilities 1.13M 0.07M -
Total cashflows from investing activities -0.65936M -1.37509M -
Net borrowings - - -
Total cash from financing activities 6.38M 14.53M 0.02M
Change to operating activities 0.02M -6.94525M -
Net income -17.80135M -3.48406M -0.00701M
Change in cash -0.25281M 3.78M 0.01M
Begin period cash flow 1.26M 0.01M 0.00000M
End period cash flow 1.01M 1.26M 0.01M
Total cash from operating activities -5.99119M -9.38230M -0.00830M
Issuance of capital stock 6.38M 0.00000M -
Depreciation 0.07M 0.07M -
Other cashflows from investing activities - - -
Dividends paid - - -
Change to inventory -0.09687M -0.02169M -
Change to account receivables -0.00498M -0.15005M -
Sale purchase of stock - - -
Other cashflows from financing activities - -0.12450M -
Change to netincome 10.56M 1.04M -
Capital expenditures 0.66M 0.06M 0.00000M
Change receivables - - -
Cash flows other operating - - -
Exchange rate changes - - -
Cash and cash equivalents changes - - -
Change in working capital 1.05M 0.00551M -0.00128M
Stock based compensation 0.07M - -
Other non cash items 7.93M - -
Free cash flow -6.65055M -0.02042M -0.00830M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CNFHF
CanaFarma Hemp Products Corp		 - -% 0.0001 - - 0.03 - 0.33 -0.0198
ZTS
Zoetis Inc		 1.20 1.57% 77.59 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.58 1.91% 31.01 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 153.91 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 -0.79 1.89% 40.92 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

CanaFarma Hemp Products Corp. engages in growing, manufacturing, processing, and selling hemp oil in the United States. The company offers hemp-based products, such as chewing gum and tincture under the YOOFORIC brand. It offers its products online. The company is based in Vancouver, Canada.

CanaFarma Hemp Products Corp

2080 - 777 Hornby Street, Vancouver, BC, Canada, V6Z 1S4

Key Executives

Name Title Year Born
Mr. Phil Klauder Acting Chief Financial Officer NA
Mr. Tyrone Ross Jr. VP of Communications NA
Mr. Vitaly Fargesen Sr. VP of Strategic Planning NA
Mr. Igor Palatnik Sr. VP of Product Acquisition NA
Mr. Daniel Kail Sr. VP of Product Acquisition NA
Mr. Edward James Kirkham Chief Grower 1974
Mr. Djibril Gibson Kagni Head of Media Management NA
Mr. Tyrone Ross Jr. Vice President of Communications NA
Mr. Vitaly Fargesen Senior Vice President of Strategic Planning NA
Mr. Igor Palatnik Senior Vice President of Product Acquisition NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions